Filing Details

Accession Number:
0001493152-20-005709
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-02 16:30:39
Reporting Period:
2020-03-31
Accepted Time:
2020-04-02 16:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1076682 Polarityte Inc. PTE Biological Products, (No Disgnostic Substances) (2836) 061529524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744816 Elliot Paul Mann 123 Wright Brothers Drive
Salt Lake City UT 84116
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-31 23,158 $1.04 415,953 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported sale was effectuated pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12,2019, as amended November 19, 2019. The sale is intended to cover withholding taxes resulting from vesting ofrestricted stock units that were previously reported on Table I.
  2. The reported price is a weighted average price. The shares were sold in multiple transactions at prices ranging from$1.00 to $1.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, orthe staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price that was included in the calculation of the weighted average price.